
Global Ventilators Market Size Study, by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) and Regio
Description
The global ventilators market is valued at approximately USD 3.86 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to 2032, reaching an estimated USD 5.84 billion by 2032. The demand for ventilators is significantly fueled by the rising incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and Acute Respiratory Distress Syndrome (ARDS). Additionally, aging populations worldwide, who are more susceptible to severe respiratory conditions, are further escalating market growth. The integration of artificial intelligence (AI), remote patient monitoring, and closed-loop ventilation technologies into ventilator systems is improving treatment efficacy, enabling real-time patient monitoring and personalized ventilation support.
The intensive care ventilators segment accounted for the largest market share due to its essential role in managing critically ill patients with acute respiratory failure, severe pneumonia, and post-surgical complications. Innovations such as AI-powered ventilators, lung-protective ventilation techniques, and automated respiratory algorithms are revolutionizing ICU care. Additionally, increasing government investments in ICU infrastructure, reimbursement policies for ventilatory support, and the expansion of healthcare facilities, particularly in emerging markets, continue to drive the adoption of advanced ventilators.
The hospitals and clinics segment dominates the market due to its high patient influx requiring critical care, emergency treatment, and respiratory therapy. Hospitals account for a significant demand for both invasive and non-invasive ventilators, especially in intensive care units (ICUs), emergency wards, and neonatal intensive care units (NICUs). Furthermore, homecare ventilators are gaining traction due to rising hospital costs, improved patient comfort, and increasing prevalence of long-term respiratory conditions requiring home-based care.
The Asia Pacific region is expected to experience the highest growth rate in the ventilators market, driven by increasing pollution levels, higher rates of respiratory disorders, rising investments in healthcare infrastructure, and the expansion of ICU bed capacity in countries like China, India, and Japan. Moreover, the availability of cost-effective ventilators manufactured by regional players is enhancing accessibility to life-saving respiratory devices across developing nations. Government-backed healthcare policies and a surge in hospital admissions due to an aging population further contribute to the strong market growth in the region.
Major Market Players Included in this Report:
• ResMed (US)
• Getinge AB (Sweden)
• Koninklijke Philips N.V. (Netherlands)
• Drägerwerk AG & CO. KGAA (Germany)
• ICU Medical, Inc. (US)
• Asahi Kasei Corporation (Japan)
• GE Healthcare (US)
• Baxter (US)
• Vyaire Medical, Inc. (US)
• Hamilton Medical (Switzerland)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Nihon Kohden Corporation (Japan)
• Air Liquide (France)
• Skanray Technologies (India)
• aXcent Medical GmbH (Germany)
The Detailed Segments and Sub-Segments of the Market are Explained Below:
By Mobility
• Intensive Care Ventilators
• Transportable Ventilators
By Type
• Adult & Pediatric Ventilators
• Neonatal Ventilators
By Interface
• Invasive Ventilation
• Non-Invasive Ventilation
• Hybrid Ventilation
By Mode
• Volume-Mode Ventilation
• Pressure-Mode Ventilation
• Combined-Mode Ventilation
By Care Setting
• Hospitals & Clinics
• Homecare Settings
• Ambulatory Care Centers
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of MEA
Years Considered for the Study:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of the geographical landscape with country-level insights
• Competitive landscape with information on major market players
• Evaluation of key business strategies and future market trends
• Analysis of demand-side and supply-side market trends
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
The intensive care ventilators segment accounted for the largest market share due to its essential role in managing critically ill patients with acute respiratory failure, severe pneumonia, and post-surgical complications. Innovations such as AI-powered ventilators, lung-protective ventilation techniques, and automated respiratory algorithms are revolutionizing ICU care. Additionally, increasing government investments in ICU infrastructure, reimbursement policies for ventilatory support, and the expansion of healthcare facilities, particularly in emerging markets, continue to drive the adoption of advanced ventilators.
The hospitals and clinics segment dominates the market due to its high patient influx requiring critical care, emergency treatment, and respiratory therapy. Hospitals account for a significant demand for both invasive and non-invasive ventilators, especially in intensive care units (ICUs), emergency wards, and neonatal intensive care units (NICUs). Furthermore, homecare ventilators are gaining traction due to rising hospital costs, improved patient comfort, and increasing prevalence of long-term respiratory conditions requiring home-based care.
The Asia Pacific region is expected to experience the highest growth rate in the ventilators market, driven by increasing pollution levels, higher rates of respiratory disorders, rising investments in healthcare infrastructure, and the expansion of ICU bed capacity in countries like China, India, and Japan. Moreover, the availability of cost-effective ventilators manufactured by regional players is enhancing accessibility to life-saving respiratory devices across developing nations. Government-backed healthcare policies and a surge in hospital admissions due to an aging population further contribute to the strong market growth in the region.
Major Market Players Included in this Report:
• ResMed (US)
• Getinge AB (Sweden)
• Koninklijke Philips N.V. (Netherlands)
• Drägerwerk AG & CO. KGAA (Germany)
• ICU Medical, Inc. (US)
• Asahi Kasei Corporation (Japan)
• GE Healthcare (US)
• Baxter (US)
• Vyaire Medical, Inc. (US)
• Hamilton Medical (Switzerland)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Nihon Kohden Corporation (Japan)
• Air Liquide (France)
• Skanray Technologies (India)
• aXcent Medical GmbH (Germany)
The Detailed Segments and Sub-Segments of the Market are Explained Below:
By Mobility
• Intensive Care Ventilators
• Transportable Ventilators
By Type
• Adult & Pediatric Ventilators
• Neonatal Ventilators
By Interface
• Invasive Ventilation
• Non-Invasive Ventilation
• Hybrid Ventilation
By Mode
• Volume-Mode Ventilation
• Pressure-Mode Ventilation
• Combined-Mode Ventilation
By Care Setting
• Hospitals & Clinics
• Homecare Settings
• Ambulatory Care Centers
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of MEA
Years Considered for the Study:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of the geographical landscape with country-level insights
• Competitive landscape with information on major market players
• Evaluation of key business strategies and future market trends
• Analysis of demand-side and supply-side market trends
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Table of Contents
285 Pages
- Chapter 1. Global Veterinary Pharmacovigilance Market Executive Summary
- 1.1. Global Veterinary Pharmacovigilance Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Solution
- 1.3.2. By Type
- 1.3.3. By Product
- 1.3.4. By Animal Type
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Veterinary Pharmacovigilance Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Veterinary Pharmacovigilance Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing Veterinary Drug Approvals & Regulatory Compliance
- 3.1.2. Rising Pet Ownership & Livestock Industry Expansion
- 3.1.3. Growing Demand for Pharmacovigilance Software & Services
- 3.2. Market Challenges
- 3.2.1. High Implementation Costs of Pharmacovigilance Solutions
- 3.2.2. Complex Regulatory Frameworks Across Regions
- 3.3. Market Opportunities
- 3.3.1. Integration of AI & Machine Learning in Veterinary Pharmacovigilance
- 3.3.2. Expansion of Pharmacovigilance Services for Companion Animals
- Chapter 4. Global Veterinary Pharmacovigilance Market Industry Analysis
- 4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
- 4.1.7. Porter’s 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Veterinary Pharmacovigilance Market Size & Forecasts by Solution (2022-2032)
- 5.1. Segment Dashboard
- 5.2. Global Veterinary Pharmacovigilance Market: Solution Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Software
- 5.2.2. Services
- Chapter 6. Global Veterinary Pharmacovigilance Market Size & Forecasts by Type (2022-2032)
- 6.1. Segment Dashboard
- 6.2. Global Veterinary Pharmacovigilance Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. In-house
- 6.2.2. Contract Outsourcing
- Chapter 7. Global Veterinary Pharmacovigilance Market Size & Forecasts by Product (2022-2032)
- 7.1. Segment Dashboard
- 7.2. Global Veterinary Pharmacovigilance Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Biologics
- 7.2.2. Anti-Infective
- 7.2.3. Other Products
- Chapter 8. Global Veterinary Pharmacovigilance Market Size & Forecasts by Animal Type (2022-2032)
- 8.1. Segment Dashboard
- 8.2. Global Veterinary Pharmacovigilance Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Dogs
- 8.2.2. Cats
- 8.2.3. Other Animal Types
- Chapter 9. Global Veterinary Pharmacovigilance Market Size & Forecasts by Region (2022-2032)
- 9.1. North America Veterinary Pharmacovigilance Market
- 9.1.1. U.S. Veterinary Pharmacovigilance Market
- 9.1.2. Canada Veterinary Pharmacovigilance Market
- 9.1.3. Mexico Veterinary Pharmacovigilance Market
- 9.2. Europe Veterinary Pharmacovigilance Market
- 9.3. Asia-Pacific Veterinary Pharmacovigilance Market
- 9.4. Latin America Veterinary Pharmacovigilance Market
- 9.5. Middle East & Africa Veterinary Pharmacovigilance Market
- Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. ArisGlobal
- 10.1.2. Accenture
- 10.1.3. Ennov
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- List of Tables
- 1. Global Veterinary Pharmacovigilance Market Estimates & Forecasts by Region (2022-2032)
- 2. Veterinary Pharmacovigilance Market Size by Solution (USD Billion, 2022-2032)
- 3. Adoption of Pharmacovigilance Software Across Animal Healthcare Facilities (2022-2032)
- 4. Growth in Veterinary Drug Approvals by Region (2022-2032)
- 5. Investment Trends in Veterinary Pharmacovigilance Startups (2022-2032)
- 6. Market Share of Key Players in Veterinary Pharmacovigilance (2022-2032)
- 7. Regulatory Guidelines for Veterinary Pharmacovigilance in Key Markets
- (This list is not complete; the final report contains more than 100 tables.)
- List of Figures
- 1. Global Veterinary Pharmacovigilance Market Trends (2022-2032)
- 2. Growth of Veterinary Drug Approvals and Pharmacovigilance Compliance (2022-2032)
- 3. Regional Breakdown of Veterinary Pharmacovigilance Market (2022-2032)
- 4. Adoption Rate of AI-Based Veterinary Pharmacovigilance Solutions (2022-2032)
- 5. Competitive Landscape of the Veterinary Pharmacovigilance Market (2022-2032)
- 6. Expansion of Contract Outsourcing in Veterinary Pharmacovigilance (2022-2032)
- 7. Market Growth of Pharmacovigilance Services for Companion Animals (2022-2032)
- (This list is not complete; the final report contains more than 50 figures.)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.